Development of a gene carrier using a triblock co-polyelectrolyte with poly(ethylene imine)-poly(lactic acid)-poly(ethylene glycol)
Source abstract
Abstract
The success of gene therapy mainly depends on the carriers for effective gene delivery. A non-viral vector using a cationic block co-polyelectrolyte, PEI-PLA-PEG polyethyleneimine-poly(lactic acid)-poly(ethylene glycol)) was developed as a potential gene carrier. The cationic PEI-PLA-PEG showed less toxicity compared to PEI and formed a gene nanocomplex (termed polyplex) by interaction with plasmid DNA or small interference RNA. The polyplex showed smaller particle size and greater positive zeta potential by increasing the high polymer nitrogen/DNA phosphate ratio. The polyplex with a nitrogen/DNA phosphate ratio of 16 or 32 demonstrated higher gene transfection by fluorescence imaging, flow cytometry measurement, and β-galactosidase activity. In particular, the polyplex with therapeutic histone deacetylase small interference RNA at nitrogen/DNA phosphate ratio 16 showed the most favorable properties with definite tumor growth inhibition. The synthetic PEI-PLA-PEG also showed less toxicity and would, therefore, be a great potential gene carrier, particularly given that small interference RNA delivery does not increase the charge density of small interference RNA due to the formation of a stable complex through conjugation with PLA-PEG.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
College of Pharmacy, Chung-Ang University, Seoul, Korea
Department of Biotechnology, The Catholic University of Korea, Bucheon, Republic of Korea
School of Pharmacy, SungKyunKwan University, Suwon, Korea
Funding
a grant from Ministry of Food and Drug safety · National Research Foundation of Korea (NRF) grant funded by the Korean government · by the National Research Foundation of Korea (NRF) grant funded by the Korean government
References (58)
Show source-provided references
1. 10.1006/mthe.2000.014210.1006/mthe.2000.0142 ↗
2. 10.1038/nrg376310.1038/nrg3763 ↗
3. 10.1016/j.actbio.2010.06.01610.1016/j.actbio.2010.06.016 ↗
4. 10.1016/j.polymer.2009.06.04310.1016/j.polymer.2009.06.043 ↗
5. 10.1016/j.copbio.2010.07.00310.1016/j.copbio.2010.07.003 ↗
6. 10.1016/S0168-3659(01)00547-810.1016/S0168-3659(01)00547-8 ↗
7. 10.1007/BF0321859610.1007/BF03218596 ↗
8. 10.1007/s00253-003-1321-810.1007/s00253-003-1321-8 ↗
9. 10.1080/1061186070179435310.1080/10611860701794353 ↗
10. 10.1177/088391151348189310.1177/0883911513481893 ↗
11. 10.1021/acs.molpharmaceut.5b0051310.1021/acs.molpharmaceut.5b00513 ↗
12. 10.1016/j.jconrel.2009.12.00710.1016/j.jconrel.2009.12.007 ↗
13. 10.1016/j.ejpb.2014.04.01310.1016/j.ejpb.2014.04.013 ↗
14. 10.1016/S0168-3659(02)00178-510.1016/S0168-3659(02)00178-5 ↗
15. 10.1016/j.addr.2009.08.00410.1016/j.addr.2009.08.004 ↗
16. 10.1016/j.ijpharm.2010.08.02610.1016/j.ijpharm.2010.08.026 ↗
17. 10.1016/S0168-3659(97)00251-410.1016/S0168-3659(97)00251-4 ↗
18. 10.18632/oncotarget.461410.18632/oncotarget.4614 ↗
19. 10.1016/j.biomaterials.2013.08.06310.1016/j.biomaterials.2013.08.063 ↗
20. 10.1002/mabi.20140046310.1002/mabi.201400463 ↗
21. 10.1016/S0006-2952(98)00098-710.1016/S0006-2952(98)00098-7 ↗
22. 10.1002/jgm.77310.1002/jgm.773 ↗
23. 10.1038/sj.gt.330193810.1038/sj.gt.3301938 ↗
24. 10.1023/A:101486190047810.1023/A:1014861900478 ↗
25. 10.1021/bc049754j10.1021/bc049754j ↗
26. 10.1016/j.jconrel.2009.07.00910.1016/j.jconrel.2009.07.009 ↗
27. 10.1016/S0169-409X(01)00202-210.1016/S0169-409X(01)00202-2 ↗
28. 10.1016/S0142-9612(03)00029-210.1016/S0142-9612(03)00029-2 ↗
29. 10.1021/bc025529v10.1021/bc025529v ↗
30. 10.1016/j.biotechadv.2012.09.00210.1016/j.biotechadv.2012.09.002 ↗
31. 10.1038/nmat262610.1038/nmat2626 ↗
32. 10.1248/bpb.30.177310.1248/bpb.30.1773 ↗
33. 10.1016/j.jconrel.2006.06.03010.1016/j.jconrel.2006.06.030 ↗
34. 10.1021/ma034390w10.1021/ma034390w ↗
35. 10.1016/j.biomaterials.2008.07.03610.1016/j.biomaterials.2008.07.036 ↗
36. 10.1016/j.jconrel.2012.04.02710.1016/j.jconrel.2012.04.027 ↗
37. Lim C · Int J Nanomedicine · 2016 · 11 · 703
38. 10.1177/088391151143600310.1177/0883911511436003 ↗
39. 10.1023/A:101615283196310.1023/A:1016152831963 ↗
40. 10.1021/bc049743q10.1021/bc049743q ↗
41. 10.1002/marc.20100033710.1002/marc.201000337 ↗
42. 10.1021/bc960063010.1021/bc9600630 ↗
43. 10.1016/j.biomaterials.2009.07.01210.1016/j.biomaterials.2009.07.012 ↗
44. 10.1021/la011393y10.1021/la011393y ↗
45. 10.1021/bc000120w10.1021/bc000120w ↗
46. 10.1007/s12272-008-1126-510.1007/s12272-008-1126-5 ↗
47. 10.1039/c0nr00680g10.1039/c0nr00680g ↗
48. 10.1002/jbm.a.3134310.1002/jbm.a.31343 ↗
49. 10.1016/j.biomaterials.2011.06.06410.1016/j.biomaterials.2011.06.064 ↗
50. Rezvani Amin Z · Iran J Basic Med Sci · 2013 · 16 · 150
51. 10.1016/S0032-3861(98)00643-010.1016/S0032-3861(98)00643-0 ↗
52. 10.1016/S0169-409X(02)00228-410.1016/S0169-409X(02)00228-4 ↗
53. 10.1016/j.biomaterials.2004.07.05010.1016/j.biomaterials.2004.07.050 ↗
54. 10.1007/BF0278933410.1007/BF02789334 ↗
55. 10.1002/bip.2103210.1002/bip.21032 ↗
56. 10.1038/mt.2013.5410.1038/mt.2013.54 ↗
57. 10.1002/ijc.2515110.1002/ijc.25151 ↗
58. 10.1016/j.bbrc.2003.09.04310.1016/j.bbrc.2003.09.043 ↗